Instil Bio, Inc. (TIL)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Sep 04, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Shareholders Equity (Quarterly) : 107.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 107.38M |
| March 31, 2026 | 110.70M |
| December 31, 2025 | 113.87M |
| September 30, 2025 | 120.42M |
| June 30, 2025 | 131.67M |
| March 31, 2025 | 144.91M |
| December 31, 2024 | 169.44M |
| September 30, 2024 | 176.33M |
| June 30, 2024 | 195.02M |
| March 31, 2024 | 205.83M |
| December 31, 2023 | 225.83M |
| September 30, 2023 | 234.02M |
| Date | Value |
|---|---|
| June 30, 2023 | 296.52M |
| March 31, 2023 | 311.15M |
| December 31, 2022 | 363.60M |
| September 30, 2022 | 410.59M |
| June 30, 2022 | 458.33M |
| March 31, 2022 | 508.56M |
| December 31, 2021 | 555.20M |
| September 30, 2021 | 601.42M |
| June 30, 2021 | 635.47M |
| March 31, 2021 | 665.15M |
| December 31, 2020 | 292.37M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.71M |
| Total Liabilities (Quarterly) | 90.33M |
| Debt to Equity Ratio | 0.8141 |
| Current Ratio | 21.67 |
| Net Debt Paydown Yield | -0.29% |